We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

The list for the next round of medicines that will ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

The sharp increase in R&D cost is directly related to the rise in the number of experimental drugs and vaccines of GSK in Phase III studies or at the registration stage. So, from the list of ...

The list is sorted in ascending order of hedge ... and endometrial cancer in addition to other drugs. GSK plc (NYSE:GSK) reported solid financial results for fiscal Q4 2024, reflecting strong ...